Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment
This episode explores groundbreaking qualitative research from the University of Pennsylvania on patient and caregiver perspectives in Alzheimer disease. Dr. Katie Auriemma, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, and Dr. Carolyn Chow, Penn Medicine, Philadelphia, PA, discuss findings from interviews with patients and caregivers that reveal hopes, worries, and nuanced views on AD therapies—highlighting the importance of patient-centered outcomes, shared decision-making, and aligning treatment with family goals.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
21:26
--------
21:26
Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease
In this episode, we are joined by entrepreneur and television personality, Barbara Corcoran. While many know Barbara for her business acumen and dynamic presence on Shark Tank, fewer may know the deeply personal and powerful story she shares today—her nine-year journey as a caregiver for her mother, who lived with Alzheimer disease.
In this heartfelt conversation, Barbara opens up about the early signs her family overlooked, the emotional toll of watching her mother's personality shift, and the pivotal moment that changed their approach to caregiving. From practical strategies to navigate agitation in Alzheimer disease, to profound lessons in empathy, patience, and family dynamics, Barbara’s story offers inspiration and wisdom for caregivers and physicians.
For more information, please visit www.RecognizeAlzheimersAgitation.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
17:42
--------
17:42
Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test
Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on understanding AD-related changes in the brain, details his research into the use of plasma p-tau217 as a blood-based biomarker for detecting Alzheimer disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
20:59
--------
20:59
Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group
Nicolas Villain, MD, PhD, Associate Professor of Neurology, Sorbonne University, Paris, France, discusses the International Working Group’s updated diagnostic criteria for the diagnosis and staging of Alzheimer disease, which offer an alternative definitional view of AD as a clinical-biologic construct.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
11:31
--------
11:31
Blarcamesine: An Investigational Oral Drug for Alzheimer Disease
Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral small molecule drug blarcamesine, which is under investigation as a potential treatment for Alzheimer disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Thought leaders from the field present insights from dementia research, clinical practice, and caregiving that will help you maximize the quality of life and well-being of your patients
Brasil